Body

LSUHSC research discovery provides therapeutic target for ALS

New Orleans, LA –Research led by Dr. Udai Pandey, Assistant Professor of Genetics at LSU Health Sciences Center New Orleans, has found that the ability of a protein made by a gene called FUS to bind to RNA is essential to the development of Amyotrophic Lateral Sclerosis (ALS). This discovery identifies a possible therapeutic target for the fatal neurological disease. The research will be available online in the Advanced Access section of the journal Human Molecular Genetics website, posted by December 21, 2012. It will be published in an upcoming issue of the journal.

Super-fine sound beam could one day be an invisible scalpel

ANN ARBOR—A carbon-nanotube-coated lens that converts light to sound can focus high-pressure sound waves to finer points than ever before. The University of Michigan engineering researchers who developed the new therapeutic ultrasound approach say it could lead to an invisible knife for noninvasive surgery.

Pigs in southern China infected with avian flu

Researchers report for the first time the seroprevalence of three strains of avian influenza viruses in pigs in southern China, but not the H5N1 avian influenza virus. Their research, published online ahead of print in the Journal of Clinical Microbiology, has implications for efforts to protect the public health from pandemics.

Study reveals that animals contribute to seagrass dispersal

(December 19, 2012) Look out the window and you're likely to see the dispersal of seeds—dandelion tufts in the wind, a squirrel burying an acorn, a robin flying off with a dogwood fruit. You might even have a burr "velcroed" to your sock.

Scripps Florida scientists develop new compound that reverses fatty liver disease

JUPITER, FL, December 19, 2012 – Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed the first synthetic compound that can reverse the effects of a serious metabolic condition known as fatty liver disease. True to its name, the disease involves an abnormal buildup of fat in the liver.

Soybeans a source of valuable chemical

The humble soybean could become an inexpensive new source of a widely used chemical for plastics, textiles, drugs, solvents and as a food additive.

Succinic acid, traditionally drawn from petroleum, is one focus of research by Rice chemists George Bennett and Ka-Yiu San. In 2004, the Department of Energy named succinic acid one of 12 "platform" chemicals that could be produced from sugars by biological means and turned into high-value materials.

Are bacteria making you hungry?

Over the last half decade, it has become increasingly clear that the normal gastrointestinal (GI) bacteria play a variety of very important roles in the biology of human and animals. Now Vic Norris of the University of Rouen, France, and coauthors propose yet another role for GI bacteria: that they exert some control over their hosts' appetites. Their review was published online ahead of print in the Journal of Bacteriology.

Unraveling the threads: Simplest cotton genome offers clues for fiber improvements

From the stockings decorating mantles to the new outfits in display windows calling to shoppers, cotton is woven into the fabric of the holiday season. For bioenergy researchers, however, fiber composition matters more than color and texture as each cotton strand is composed of more than two dozen coils of cellulose, a target biomass for next-generation biofuels.

Scientists develop technique to help prevent inherited disorders in humans

NEW YORK, NY (December 19, 2012) – A joint team of scientists from The New York Stem Cell Foundation (NYSCF) Laboratory and Columbia University Medical Center (CUMC) has developed a technique that may prevent the inheritance of mitochondrial diseases in children. The study is published online today in Nature.

NYSCF and CUMC scientists develop scientific technique to help prevent inherited disorders in humans

NEW YORK, NY (December 19, 2012) – A joint team of scientists from The New York Stem Cell Foundation (NYSCF) Laboratory and Columbia University Medical Center (CUMC) has developed a technique that may prevent the inheritance of mitochondrial diseases in children. The study is published online today in Nature.

Genomic frontier: The unexplored animal kingdom

HOUSTON -- (Dec. 19, 2012) -- A new report in the journal Nature unveils three of the first genomes from a vast, understudied swath of the animal kingdom that includes as many as one-quarter of Earth's marine species.

UC Irvine study of leaping toads reveals muscle-protecting mechanism

Irvine, Calif., Dec. 19, 2012 — Most people are impressed by how a toad jumps. UC Irvine biologist Emanuel Azizi is more impressed by how one lands.

An assistant professor of ecology & evolutionary biology who specializes in muscle physiology and biomechanics, Azizi found that nature's favorite leapers possess a neuromuscular response that's specific to the intensity of a landing – a mechanism that protects muscles from injury upon impact.

Healthy lifestyle during menopause may decrease breast cancer risk later on

Obese, postmenopausal women are at greater risk for developing breast cancer and their cancers tend to be more aggressive than those in lean counterparts. A University of Colorado Cancer Center study published in the December issue of the journal Cancer Research shows how this risk might be prevented.

Protein creates paths for growing nerve cells

Working with mice, Johns Hopkins scientists have discovered that a particular protein helps nerve cells extend themselves along the spinal cord during mammalian development. Their results shed light on the subset of muscular dystrophies that result from mutations in the gene that holds the code for the protein, called dystroglycan, and also show how the nerve and muscle failings of the degenerative diseases are related.

Toward a pill to enable celiac patients to eat foods containing gluten

Scientists are reporting an advance toward development of a pill that could become celiac disease's counterpart to the lactase pills that people with lactose intolerance can take to eat dairy products without risking digestive upsets. They describe the approach, which involves an enzyme that breaks down the gluten that causes celiac symptoms, in the Journal of the American Chemical Society.